Chonluten

Chonluten is a short peptide discussed for breathing comfort after illness and for asthma, chronic bronchitis or smoking-related irritation. Favorable accounts describe easier breaths and less coughing, often while also using Bronchogen. Other accounts describe no early change; the reports do not demonstrate repaired lungs or establish a respiratory treatment.

Three amino acids. Chonluten is synthetic Glu-Asp-Gly, abbreviated EDG, from the Khavinson bioregulator family. The 2022 laboratory paper identifies it as peptide P5. Avolio et al. 2022 — THP-1 inflammatory pathways experiment (Official context · Accessed 2026-09-30)

Forms and names matter. Capsules, sublingual products held under the tongue, and research injectables appear in discussion. Bronchogen is a different peptide; Taxorest is marketed as a natural lung-peptide complex. Similar lung branding does not make these products or their milligram amounts equivalent.

Source context — Avolio et al. 2022 — THP-1 inflammatory pathways experiment: In-vitro human leukemia-derived cell line, not a treated human or lung epithelium. Khavinson co-author; no administered human dose, PK or safety measurement. PMC captcha and MDPI direct open failed; this PDF body was inspected. Supplementary apoptosis percentages not reviewed.

Chonluten is a short peptide discussed for breathing comfort after illness and for asthma, chronic bronchitis or smoking-related irritation. Favorable accounts describe easier breaths and less coughing, often while also using Bronchogen. Other accounts describe no early change; the reports do not demonstrate repaired lungs or establish a respiratory treatment.

Less difficult breathing. People seek less chest tightness or coughing and easier stairs. The preserved accounts range from subtle comfort to no detectable change. Such experiences do not establish greater oxygen uptake or reversed lung damage.

Improvement and nonresponse both belong here. The two-week nonresponse and later four-week improvement are the same author, not two independent users. The older record also retains subtle or absent change after one or two courses; its unspecified sample cannot support the former wording that many users experience this. Bronchogen bioregulator dosage — Passenger119 updates (Personal report · Accessed 2026-09-30)

More room for exercise. An asthma and smoking-history poster described more capable breathing and a slight energy increase during HIIT while stacking Chonluten with Bronchogen and also using methylene blue. The account cannot isolate Chonluten's contribution. Chonluten — Massive-Athlete-9336 experience and replies (Personal report · Accessed 2026-09-30)

Source context — Bronchogen bioregulator dosage — Passenger119 updates: One stacked account, no inspected dose/route, spirometry, comparator or discontinuation follow-up. Hidden/moderated replies remain absent. Thread date 2024-07-17; update dates display only relative ages.

Source context — Chonluten — Massive-Athlete-9336 experience and replies: Vendor-adjacent subreddit and strong vendor influence in post; unverified products, no objective lung test, exact injection route absent. Personal regimen distinguished from advice and unsupported bioavailability claim.

Injectable: one account used 1 mg daily. The CosmicNootropic poster reported 1 mg a day for 20 days; the exact injection route was unstated. Their separate capsule suggestion was two pills daily for roughly 20–30 days, without a verified milligram content. Their claim of equal oral and injectable bioavailability was unsupported. Chonluten — Massive-Athlete-9336 experience and replies (Personal report · Accessed 2026-09-30)

Oral and sublingual figures differ. The original discussion record retains commercially derived capsule figures of 10 mg once daily and 10–20 mg/day variants; higher blog charts mention one or two capsules before breakfast or two twice daily with meals. Sublingual guides mention five or six drops, three or four times daily before meals. Drop concentration is unspecified, so no milligram conversion is justified.

Injectable charts conflict. The old record preserves 200 mcg/day short pulses, 250–1,500 mcg/day longer charts, a wider 250–4,000 mcg/day band, and separate 5–10 mg subcutaneous daily or about 2 mg/day pen-style claims. Their origins are charts and secondary guides, not measured human dose finding. A separate Reddit subcutaneous chart lists 250 through 4,000 mcg across 16 weeks but leaves frequency unanswered. Chonluten (Lung repair) — circulated subcutaneous chart (Secondhand community claim · Accessed 2026-09-30)

Source context — Chonluten — Massive-Athlete-9336 experience and replies: Vendor-adjacent subreddit and strong vendor influence in post; unverified products, no objective lung test, exact injection route absent. Personal regimen distinguished from advice and unsupported bioavailability claim.

Source context — Chonluten (Lung repair) — circulated subcutaneous chart: Chart without cited original, user outcome, dosing frequency or stop interval; no assumption that listed amounts mean per day. Relative ages differ between crawls; indexed result supplies 2026-03-01 post date.

No early breakthrough, then a four-week change. Passenger119 reported unchanged symptoms after two weeks of Chonluten plus Bronchogen. At four weeks they described deeper breaths, less positional nighttime coughing and residual occasional breathlessness. Dose and route were absent. This is one course history, not a minimum waiting period. Bronchogen bioregulator dosage — Passenger119 updates (Personal report · Accessed 2026-09-30)

A contrasting immediate claim. snAp5 described increased lung capacity within seconds of injecting a Chonluten and Bronchogen stack. No lung-function measurement, amount or exact injection route accompanied it. Subjectively easier breathing is not measured capacity or evidence of immediate repair. Not every Peptide is for You — snAp5 comment (Personal report · Accessed 2026-09-30)

Course length is not effect length. The four-week update does not say how many hours one administration helped or how long improvement survived stopping. A repeatable per-dose duration is unknown from these accounts. Bronchogen bioregulator dosage — Passenger119 updates (Personal report · Accessed 2026-09-30)

Weeks off remain bioregulator lore. The original notes describe claimed persistence four to eight weeks after a course and seasonal benefits after repeated courses. They lack identifiable controlled follow-up; a long break on a calendar does not demonstrate a lasting effect.

6–8 hours injectable; 12+ hours oral are blog claims. The affiliate bodybuilding site Fit Science publishes these figures without a traceable pharmacokinetic study. They remain unsupported claims, not established human half-lives. Fit Science bodybuilding Chonluten guide (Community guide · Accessed 2026-09-30)

Short peptide does not supply a number. The preserved community explanation assumes rapid breakdown and brief circulation, followed by longer tissue signaling. That theory does not establish an EDG half-life, oral absorption percentage, or equivalence between routes.

Source context — Bronchogen bioregulator dosage — Passenger119 updates: One stacked account, no inspected dose/route, spirometry, comparator or discontinuation follow-up. Hidden/moderated replies remain absent. Thread date 2024-07-17; update dates display only relative ages.

Source context — Not every Peptide is for You — snAp5 comment: Single subjective stacked report, no dose, exact injection route, objective capacity test or follow-up. Adverse reports elsewhere in this long thread concern other peptides and are not Chonluten events.

Source context — Fit Science bodybuilding Chonluten guide: Commercial affiliate influence, unverifiable named attribution and testimonials, no linked primary PK source; unsafe assurance of long-term safety unsupported. Used only to show what claims circulate. Body changes between crawls; both opened versions share these timing claims.

Short oral courses. Commercially derived community calendars retain 10–20-day blocks, 10–30-day variants, or one-to-three-month intensives, followed by maintenance every three to six months. Spring and fall courses, roughly two or three times yearly with two-to-six-month breaks, are traditions rather than demonstrated requirements.

Injectable practice has no shared schedule. The 20-day personal account differs from old 10-day pulses with four-to-six-month breaks and eight-to-sixteen-week titration charts. Continuous daily use also appears in the preserved record. The separate 16-week Reddit chart supplies no off-cycle or answered frequency. Chonluten — Massive-Athlete-9336 experience and replies (Personal report · Accessed 2026-09-30) · Chonluten (Lung repair) — circulated subcutaneous chart (Secondhand community claim · Accessed 2026-09-30)

Source context — Chonluten — Massive-Athlete-9336 experience and replies: Vendor-adjacent subreddit and strong vendor influence in post; unverified products, no objective lung test, exact injection route absent. Personal regimen distinguished from advice and unsupported bioavailability claim.

Source context — Chonluten (Lung repair) — circulated subcutaneous chart: Chart without cited original, user outcome, dosing frequency or stop interval; no assumption that listed amounts mean per day. Relative ages differ between crawls; indexed result supplies 2026-03-01 post date.

More room for exercise. An asthma and smoking-history poster described more capable breathing and a slight energy increase during HIIT while stacking Chonluten with Bronchogen and also using methylene blue. The account cannot isolate Chonluten's contribution. Chonluten — Massive-Athlete-9336 experience and replies (Personal report · Accessed 2026-09-30)

Stacks obscure credit. The lung pair appears together or sequentially, sometimes with two-week gaps and two or three yearly repeats. These calendars are advice, not documented completed sequences. Older accounts include Taxorest two-capsule mornings for one or two months, multi-organ kits, BPC-157, TB-500, GHK-Cu and Thymosin Alpha-1. NAC, rehabilitation and smoking cessation also complicate attribution.

Bioregulator kits / multi-organ weeks: With Epitalon (pineal), Vesugen (vascular), Vilon, Thymogen/Thymalin, Pinealon, Cartalax in “system-wide” packs — single-agent lung credit is weak inside kits. [community]

Repair crossover: BPC-157 and/or TB-500 for post-illness “body + lungs” stacks; high confound risk and no combo RCTs. [community]

GHK-Cu layer: Occasional post-COVID or remodeling talk pairs copper peptide with lung bioregulators — anecdote-level only. [anecdote]

Thymosin Alpha-1: Discussed with Chonluten for post-infectious immune + epithelial framing; some protocol blogs prefer sequential rather than simultaneous courses for cleaner tracking. [community]

Accompanying measures: NAC, vitamin D, omega-3s, hydration, pulmonary rehab and smoking cessation appear alongside peptide use. These concurrent changes complicate attribution of breathing improvement. [community]

Source context — Chonluten — Massive-Athlete-9336 experience and replies: Vendor-adjacent subreddit and strong vendor influence in post; unverified products, no objective lung test, exact injection route absent. Personal regimen distinguished from advice and unsupported bioavailability claim.

Adverse reports remain part of the picture. The original community record mentions nausea or stomach discomfort with capsules, injection-site redness, sting or itch, occasional headache or feeling off, and sensitivity reactions. These are unlinked summaries with unknown frequencies and uncertain attribution, not a new verified adverse-event series.

Units, identity and real care. 1 mg equals 1,000 mcg; unlike products cannot be compared by vial size or pen units. The preserved cautions include mislabeled sequences, purity and contamination, injection risks, and missing pregnancy, breastfeeding and long-term safety information. Chonluten has no established role replacing rescue inhalers, controllers, oxygen or assessment of worsening breathlessness.